FMNHS eBulletin: Breast Cancer Research Funding opportunities from Susan G. Komen

Eligibility: Applications are open to junior faculty members working at academic institutions who have no more than six years of experience within their faculty appointment
Funding Level: Up to $300,000 over 2 years or $450,000 over 3 years.
Training Requirements: Applicants/PIs must propose a mentor committee whose purpose is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Applicant/PI’s career advancement. At least one mentor must be at the same institution as the PI and serve as the onsite representative for the entire mentor committee.
Grant Intent: CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. These grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers.

Two Research Focus Areas are included in this mechanism:

CCR-Clinical Research – for clinical faculty proposing clinical research (as defined within the RFA); and
CCR-Basic/Translational Research – for basic or clinical faculty proposing laboratory-based biomedical research.

Eligibility: Applications are open to postdoctoral fellows who have completed their doctoral degree and are at academic institutions, no more than 5 years after the date of their degree confirmation, or 5 years after completion of their residency (for physicians).
Funding Level: Up to $120,000 over 2 years or $180,000 over 3 years.
Training Requirements: Applicants/PIs must include a Lead Mentor who currently conducts breast cancer research at the same academic institution with the postdoctoral fellow. The primary purpose of the Lead Mentor and Co-Mentor (if applicable) is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Applicant/PI’s career advancement.
Grant Intent: Seek to attract and support promising scientists who are embarking on careers dedicated to breast cancer research. PDF grants provide support for basic research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer.

Two Research Focus Areas are included in this mechanism:

PDF-Clinical Research – for clinical faculty proposing clinical research (as defined within the RFA); and
PDF-Basic/Translational Research – for basic or clinical faculty proposing laboratory-based biomedical research.

Eligibility: Applications are open to researchers with a doctoral degree at academic institutions who are conducting breast cancer disparities research and are committed to support a training program with a minimum of 3 graduate students/trainees (those in a masters and/ or doctoral program) per year.
Funding Level: Up to $135,000 per year for up to 3 years for a total of $405,000.
Training Requirements: The proposed research training program should leverage the current training and research activities available at the applicant institution while also providing new training opportunities that are not currently offered. The program should provide a combination of didactic coursework and hands-on laboratory, clinical and/or public health research experience. Strong preference will be given to programs that provide a solid plan for recruiting trainees from populations affected by disparities in breast cancer outcomes.
Grant Intent: Intended to establish and/or to sustain a training program for graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. By providing funding to outstanding training programs, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research.

Key dates:

Wednesday 3 June 2015